Vanguard Group Inc Aura Biosciences, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,917,730 shares of AURA stock, worth $15.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,917,730
Previous 1,805,434
6.22%
Holding current value
$15.2 Million
Previous $16.1 Million
2.01%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding AURA
# of Institutions
93Shares Held
38.8MCall Options Held
72KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$55 Million2.75% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$46.1 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$38.8 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.1 Million5.49% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$23.9 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $232M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...